Cox regression multivariate analysis indicated that HOXB3 expression was an independent risk factor affecting OS and DFS in both total AML (P = 0.023 and 0.009, respectively) and non-M3 AML (P = 0.024 and 0.039, respectively) patients (Table 3). Here, HOXB3 is linked to acute myeloid leukemia.